OverviewThe global infectious disease diagnostics market is poised for steady expansion, with forecasts indicating a CAGR of approximately 7% over the next five years. This growth trajectory is ...

Emerging markets, breakthrough technologies, and strategic M&A reshape competitive landscapeThe global molecular cytogenetics ...

At this year's IEEE International Electron Devices Meeting (IEDM 2025), imec, a research and innovation hub in advanced ...

Commercial uranium extraction from seawater could become viable within five years thanks to a new, game-changing technology.

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Leafhopper-Inspired Nanoparticles Achieve 96% Glare Reduction in Lab Tests In A Nutshell Nature’s inspiration: Leafhoppers ...

A new computational approach developed at the University of Chicago promises to shed light on some of the world's most ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...

Washington State University researchers are using AI and simulations to pinpoint a single molecular interaction that blocks ...

The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...